GUGGENHEIM CAPITAL LLC - GALENA BIOPHARMA INC ownership

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q2 2016$26,000
-64.4%
55,646
+4.4%
0.00%
Q1 2016$73,000
+35.2%
53,301
+44.6%
0.00%
Q4 2015$54,000
-3.6%
36,854
+3.6%
0.00%
Q3 2015$56,000
-9.7%
35,588
-2.1%
0.00%
Q2 2015$62,000
+29.2%
36,362
+5.3%
0.00%
Q1 2015$48,0000.0%34,525
+8.1%
0.00%
Q4 2014$48,0000.0%31,925
+35.1%
0.00%
Q3 2014$48,000
-72.9%
23,626
-59.0%
0.00%
Q2 2014$177,000
+19.6%
57,620
-3.0%
0.00%
Q1 2014$148,000
-37.8%
59,425
+23.7%
0.00%
-100.0%
Q4 2013$238,000
+126.7%
48,032
+4.6%
0.00%
Q3 2013$105,000
+34.6%
45,904
+31.8%
0.00%
Q2 2013$78,00034,8200.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Hoxton Financial, Inc. 50,000$74,0000.04%
Alyeska Investment Group, L.P. 1,593,277$2,342,0000.02%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 31,000$46,0000.02%
GROUP ONE TRADING, L.P. 1,346,904$1,980,0000.02%
Matisse Capital 17,000$25,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 15,000$22,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 12,150$18,0000.01%
EQUITEC SPECIALISTS, LLC 19,700$29,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 153,375$225,0000.00%
OPPENHEIMER & CO INC 94,300$138,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders